Literature DB >> 20103306

Factors associated with postoperative symptoms after laparoscopic Heller myotomy.

Christian J Finley1, Jennifer Kondra, Joanne Clifton, John Yee, Richard Finley.   

Abstract

BACKGROUND: Our objective is to ascertain if preoperative and perioperative treatments affect the short- and long-term symptom frequency or symptom scores for dysphagia, regurgitation, and heartburn in patients with laparoscopic Heller myotomy for achalasia.
METHODS: From 1994 to 2008, 261 patients undergoing laparoscopic esophageal myotomy were enrolled prospectively. The diagnosis of classic achalasia was made on clinical history, barium swallow, endoscopy, and manometry. A validated symptom questionnaire and history was taken for each patient at the preoperative visit and at each postoperative visit.
RESULTS: In all, 261 patients had laparoscopic Heller myotomy during the study period. Preoperatively, 137 patients (62.3%) tried medications, 101 (38.7%) were treated with pneumatic dilation, and 29 (11.1%) were treated initially with at least one injection of botulinum toxin into the lower esophageal sphincter. In all, 134 patients (51.3%) received a Dor anterior fundoplication. On multivariate regression controlling for age and sex, preoperative dilation (p = 0.031), injection of botulinum toxin (p = 0.044), and a fundoplication (p = 0.005) were associated with significantly worse early postoperative dysphagia, with odds ratios of 2.11, 2.56, and 2.80, respectively; previous botulinum toxin injection was associated with worse late postoperative dysphagia (p = 0.001), regurgitation (p = 0.031), and heartburn (p = 0.049), with odds ratios of 5.24, 2.87, and 2.52, respectively. There was a trend for no fundoplication to be associated with late postoperative heartburn (p = 0.077) with an odds ratio of 1.80.
CONCLUSIONS: Many patients presenting for Heller myotomy have previously undergone a different form of treatment. Early postoperative dysphagia was affected by dilation, botulinum toxin injection, and fundoplication. Only botulinum toxin injection was associated with late symptoms. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103306     DOI: 10.1016/j.athoracsur.2009.10.046

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Dor against toupet fundoplication after heller myotomy. Laparoscopic technical improvements and endoscopic support.

Authors:  Stefano Pontone; Paolo Urciuoli; Paolo Pontone; Filippo Custureri
Journal:  J Gastrointest Surg       Date:  2011-07-01       Impact factor: 3.452

Review 2.  Surgical treatment for achalasia: when should it be performed, and for which patients?

Authors:  Hideyuki Kashiwagi; Nobuo Omura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

Review 3.  Therapeutic options in oesophageal dysphagia.

Authors:  Jan Tack; Giovanni Zaninotto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

4.  National outcomes of laparoscopic Heller myotomy: operative complications and risk factors for adverse events.

Authors:  Samuel W Ross; Bindhu Oommen; Blair A Wormer; Amanda L Walters; Brent D Matthews; B T Heniford; Vedra A Augenstein
Journal:  Surg Endosc       Date:  2015-01-15       Impact factor: 4.584

Review 5.  Esophageal achalasia 2011: pneumatic dilatation or laparoscopic myotomy?

Authors:  Marco G Patti; Carlos A Pellegrini
Journal:  J Gastrointest Surg       Date:  2011-10-04       Impact factor: 3.452

Review 6.  Treatment and surveillance strategies in achalasia: an update.

Authors:  Alexander J Eckardt; Volker F Eckardt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04-26       Impact factor: 46.802

Review 7.  Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature.

Authors:  Kristle L Lynch; John E Pandolfino; Colin W Howden; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

8.  Endoscopic treatment of esophageal achalasia.

Authors:  Dario Esposito; Francesco Maione; Alessandra D'Alessandro; Giovanni Sarnelli; Giovanni D De Palma
Journal:  World J Gastrointest Endosc       Date:  2016-01-25

9.  Full-thickness myotomy is associated with higher rate of postoperative gastroesophageal reflux disease.

Authors:  Xue-Hong Wang; Yu-Yong Tan; Hong-Yi Zhu; Chen-Jie Li; De-Liang Liu
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.